Skip to main content
Veterinary Medicines

INTERTOCINE-S 0.018mg/ml ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ

Not authorised
  • Oxytocin acetate

Product identification

Medicine name:
INTERTOCINE-S 0.018mg/ml ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
  • Oxytocin acetate
Target species:
  • Horse
  • Cattle
  • Sheep
  • Goat
  • Pig
  • Dog
  • Cat
Route of administration:
  • Intramuscular and intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Oxytocin acetate
    0.02
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular and intravenous use
    • Horse
      • Meat and offal, milk
        0
        day
    • Cattle
      • Meat and offal, milk
        0
        day
    • Sheep
      • Meat and offal, milk
        0
        day
    • Goat
      • Meat and offal, milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Dog
      • Not applicable
        no withdrawal period
    • Cat
      • Not applicable
        no withdrawal period
  • Subcutaneous use
    • Horse
      • Meat and offal, milk
        0
        day
    • Cattle
      • Meat and offal, milk
        0
        day
    • Sheep
      • Meat and offal, milk
        0
        day
    • Goat
      • Meat and offal, milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Dog
      • Not applicable
        no withdrawal period
    • Cat
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH01BB02
Authorisation status:
  • Surrendered
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet Hellas A.E.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International GmbH
  • Intervet International B.V.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 56324/11-08-2010/K-0036101
Date of authorisation status change: